Right now, the HALT Study is underway to provide the substantial evidence of effectiveness necessary for the full FDA approval of Felycin-CA1 (referred to as TRIV202 in HALT) for the management of ...

Felycin®-CA1 is now available by prescription via licensed veterinarians, and PBI-Gordon Companies, Inc. confirms that it has no affiliation with any online companies offering rapamycin (sirolimus) ...

Background Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) among young individuals and ...

Hypertrophic cardiomyopathy (HCM) is the most common genetic heart (cardiac) condition. It affects more than one in 500 people in the US. Genetic counseling and genetic testing can be helpful so you ...

Treadmill stress echocardiography (TSE) reveals hidden physiologic limitations in patients with asymptomatic hypertrophic cardiomyopathy (HCM), aiding in diagnosis and prognosis. Many patients with ...

Researchers have discovered the first genetic mutation associated with hypertrophic cardiomyopathy (HCM) and sudden death in golden retrievers. The work could lead to increased early detection and ...

Please provide your email address to receive an email when new articles are posted on . Black patients with hypertrophic cardiomyopathy were often diagnosed at a younger age and were less likely to ...